Financing

Proceeds from Issuance of Commercial Paper and Short-Term Borrowings

Elevance Health Proceeds from Issuance of Commercial Paper and Short-Term Borrowings increased by 40.6% to $724.00M in Q1 2026 compared to the prior quarter.

Analysis

StatementCash Flow Statement
SectionFinancing
First reportedQ1 2013
Last reportedQ1 2026Apr 22, 2026
Metric ID: hon_proceeds_from_short_term_debt_and_cp

Historical Data

13 periods
 Q2 '21Q3 '21Q4 '21Q3 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q4 '24Q1 '25Q4 '25Q1 '26
Value$175.00M$0.00$1.20B$90.00M$325.00M-$325.00M$0.00$225.00M$1.35B$65.00M$0.00$515.00M$724.00M
QoQ Change-100.0%-92.5%+261.1%-200.0%+100.0%+500.0%-95.2%-100.0%+40.6%
YoY Change-100.0%+315.4%-71.1%-100.0%+692.3%
Range-$325.00M$1.35B
CAGR+60.5%
Avg YoY Growth+147.3%
Median YoY Growth-71.1%
Current Streak2 quarters growth

Proceeds from Issuance of Commercial Paper and Short-Term Borrowings at Other Companies

Frequently Asked Questions

What is Elevance Health's proceeds from issuance of commercial paper and short-term borrowings?
Elevance Health (ELV) reported proceeds from issuance of commercial paper and short-term borrowings of $724.00M in Q1 2026.